◆英語タイトル:Lawson Health Research Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10699
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Lawson Health Research Institute (Lawson) is a hospital-based research institute that offers educational and research programs. The institute’ services include health research programs, medical research programs, educational research programs, scientific research programs, patient care services, medical care, clinical trials and healthcare services. It also provides surgical technologies and advanced robotics services, clinical research, cancer research, clinical investigations and therapeutics, cyclotron and pet radiochemistry, kidney clinical research, renal health discovery and translation services. Lawson offers cancer research laboratory programs, children’s health research, diabetes and endocrinology, critical illness, mental health research, imaging and microbiome and probiotics services, among others. The institution provides its services through its centers, facilities and medical departments. Lawson is headquartered in London, Ontario, Canada.
Lawson Health Research Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lawson Health Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
StemCell Technologies Enters into Licensing Agreement with Lawson Health Research Institute 10
Yabao Pharma Enters into Licensing Agreement with Lawson Health Research Institute 11
Novare Pharma Enters into Licensing Agreement with Lawson Health Research Institute 12
Lawson Health Research Institute – Key Competitors 13
Lawson Health Research Institute – Key Employees 14
Lawson Health Research Institute – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Government and Public Interest 16
Oct 24, 2018: New clinical protocol after general surgery cuts opioid prescribing in half 16
Jul 11, 2018: Health researchers in London bring in over $11 million of national funding 17
May 03, 2018: Researchers find gut microbiome plays an important role in atherosclerosis 18
Apr 25, 2018: How the brain is folded provides researchers with an accurate marker to predict psychosis in high-risk patients 19
Mar 05, 2018: Early psychosis programs significantly reduce patient mortality, study finds 20
Feb 26, 2018: Lawson researchers receive $4.4 million to study personalized medicine at LHSC 22
Jan 29, 2018: New radiation techniques could improve quality of life for lung cancer patients 24
Jan 25, 2018: London researchers net over $8.6 million in CIHR funding 25
Other Significant Developments 26
Jul 09, 2018: Synthetic surfactant could ease breathing for patients with lung disease and injury 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28
List of Tables
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lawson Health Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lawson Health Research Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
StemCell Technologies Enters into Licensing Agreement with Lawson Health Research Institute 10
Yabao Pharma Enters into Licensing Agreement with Lawson Health Research Institute 11
Novare Pharma Enters into Licensing Agreement with Lawson Health Research Institute 12
Lawson Health Research Institute, Key Competitors 13
Lawson Health Research Institute, Key Employees 14
List of Figures
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lawson Health Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8